Last reviewed · How we verify

NCT04317612: MINDBERRY

Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment

Completed NA Last updated 1 March 2024
What this trial tests

NA trial testing Active berry product in Cognitive Impairment, Mild in 96 participants. Completed in 1 February 2024.

Timeline
3 June 2020
Primary endpoint
1 February 2024
1 February 2024

Quick facts

Lead sponsorRegion Skane
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment96
Start date3 June 2020
Primary completion1 February 2024
Estimated completion1 February 2024
Sites2 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Skane — full company profile →

Who can join

55 and older, any sex, with Cognitive Impairment, Mild or Memory Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the current study is to investigate whether daily intake of Nordic berries for 12 weeks can improve cognitive abilities of adults with mild cognitive impairment, and whether the effect can be linked to changes in metabolic parameters.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A mixture of Nordic berries improves cognitive function, metabolic function and alters the gut microbiota in C57Bl/6J male mice.
    Huang F, Marungruang N, Martinsson I, Camprubí Ferrer L, et al · · 2023 · cited 5× · PMID 37854349 · DOI 10.3389/fnut.2023.1257472

Verify or expand the search:

Other trials of Active berry product

Trials testing the same drug.

Other recruiting trials for Cognitive Impairment, Mild

Currently open trials in the same condition.

Other Region Skane trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04317612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing